Cargando…
Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter p...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281695/ https://www.ncbi.nlm.nih.gov/pubmed/37419768 http://dx.doi.org/10.1016/j.explore.2023.06.009 |
_version_ | 1785061047655202816 |
---|---|
author | MAHJOUB, Lobna YOUSSEF, Rym YAAKOUBI, Hajer SALAH, Houda BEN JABALLAH, Rahma MEJRI, Moez SEKMA, Adel TRABELSI, Imen NOUIRA, Semir KHROUF, Mariem SOLTANE, Houda BEN MEZGAR, Zied BOUKADIDA, Lotfi ZORGATI, Asma BOUKEF, Riadh |
author_facet | MAHJOUB, Lobna YOUSSEF, Rym YAAKOUBI, Hajer SALAH, Houda BEN JABALLAH, Rahma MEJRI, Moez SEKMA, Adel TRABELSI, Imen NOUIRA, Semir KHROUF, Mariem SOLTANE, Houda BEN MEZGAR, Zied BOUKADIDA, Lotfi ZORGATI, Asma BOUKEF, Riadh |
author_sort | MAHJOUB, Lobna |
collection | PubMed |
description | BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. RESULTS: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the (5th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. CONCLUSIONS: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness. |
format | Online Article Text |
id | pubmed-10281695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102816952023-06-21 Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. MAHJOUB, Lobna YOUSSEF, Rym YAAKOUBI, Hajer SALAH, Houda BEN JABALLAH, Rahma MEJRI, Moez SEKMA, Adel TRABELSI, Imen NOUIRA, Semir KHROUF, Mariem SOLTANE, Houda BEN MEZGAR, Zied BOUKADIDA, Lotfi ZORGATI, Asma BOUKEF, Riadh Explore (NY) Article BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. RESULTS: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the (5th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. CONCLUSIONS: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness. Elsevier Inc. 2023-06-20 /pmc/articles/PMC10281695/ /pubmed/37419768 http://dx.doi.org/10.1016/j.explore.2023.06.009 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article MAHJOUB, Lobna YOUSSEF, Rym YAAKOUBI, Hajer SALAH, Houda BEN JABALLAH, Rahma MEJRI, Moez SEKMA, Adel TRABELSI, Imen NOUIRA, Semir KHROUF, Mariem SOLTANE, Houda BEN MEZGAR, Zied BOUKADIDA, Lotfi ZORGATI, Asma BOUKEF, Riadh Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title_full | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title_fullStr | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title_full_unstemmed | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title_short | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
title_sort | melatonin, vitamins and minerals supplements for the treatment of covid-19 and covid-like illness: a prospective, randomized, double-blind multicenter study. |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281695/ https://www.ncbi.nlm.nih.gov/pubmed/37419768 http://dx.doi.org/10.1016/j.explore.2023.06.009 |
work_keys_str_mv | AT mahjoublobna melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT youssefrym melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT yaakoubihajer melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT salahhoudaben melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT jaballahrahma melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT mejrimoez melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT sekmaadel melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT trabelsiimen melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT nouirasemir melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT khroufmariem melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT soltanehoudaben melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT mezgarzied melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT boukadidalotfi melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT zorgatiasma melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy AT boukefriadh melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy |